CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 145 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,177 | +135.1% | 2,091 | +72.7% | 0.00% | – |
| Q2 2023 | $13,260 | +132500.0% | 1,211 | +5.3% | 0.00% | – |
| Q1 2023 | $10 | +42.9% | 1,150 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 1,150 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,150 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -82.4% | 1,150 | -79.0% | 0.00% | – |
| Q1 2022 | $17,000 | -45.2% | 5,470 | -47.8% | 0.00% | – |
| Q4 2021 | $31,000 | +675.0% | 10,470 | +810.4% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 1,150 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 1,150 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -66.7% | 1,150 | -56.6% | 0.00% | – |
| Q4 2020 | $15,000 | +50.0% | 2,650 | +89.3% | 0.00% | – |
| Q3 2020 | $10,000 | +100.0% | 1,400 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 1,400 | -25.5% | 0.00% | – |
| Q4 2019 | $4,000 | -20.0% | 1,880 | +102.2% | 0.00% | – |
| Q3 2019 | $5,000 | +66.7% | 930 | +116.3% | 0.00% | – |
| Q2 2019 | $3,000 | -50.0% | 430 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +100.0% | 430 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 430 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |